IL2 (Interleukin 2) Recombinant Human Protein
Product Image
Gibco™

IL2 (Interleukin 2) Recombinant Human Protein

Recombinant Human Interleukin 2 (IL2) is a bioactive protein intended for use in cell culture applications. IL2 causes proliferation ofMás información
Have Questions?
Número de catálogo CTP0021
Precio (MXN)
-
Recombinant Human Interleukin 2 (IL2) is a bioactive protein intended for use in cell culture applications. IL2 causes proliferation of T cells and is a central regulator of immune responses. The lyophilized, E. coli-expressed IL2 Recombinant Human is verified for activity through dose-dependent proliferation of mouse CTLL-2 cells.

Highly Pure—minimizes interference from other proteins or contaminants
Active—get more results with less protein

High Purity
To help verify that GIBCO™ Recombinant growth factors are of the highest quality, each protein is analyzed for purity, along with structural homogeneity, to help ensure a biologically active protein. The purity of each GIBCO™ recombinant growth factor is verified by SDS-PAGE to be over 95% pure and to have endotoxin levels below 0.1 ng/μg.

High Biological Activity
All GIBCO™ Recombinant growth factors are verified for activity. Each lot has its own ED50 determined using an activity assay based on a specific function of the growth factor. The activity of our IL2 Recombinant Human growth factor is determined by the dose dependent proliferation of mouse CTLL-2 cells to have an ED50 range of 0.08–0.5 ng/mL. Optimal concentration for individual applications should be determined by a dose response assay.

Related Links
Our Full Collection of GIBCO™ Growth Factors
For Research Use Only. Not for use in diagnostic procedures.
Especificaciones
Actividad0.281 ng/ml
BioensayoProliferation of CTLL-2 cells
ClasificaciónCarrier-Free
Nivel de endotoxinas< 0.1 ng/μg
Sistema de expresiónE. coli
Alias de genIL-2 (Interleukin 2)
Peso molecular15.5 kDa
Línea de productosGibco
Familia de proteínasCytokines & Receptors
Forma de proteínaRecombinant, Ligand, Mutant
Subtipo de proteínaInterleukins
Método de purificaciónGel-Purified
Grado de pureza o calidad95 %
Cantidad100 μg
ReactividadHuman
Categoría de investigaciónClinical Research, Signal Transduction, Oncology, Stem Cell Research, Drug Development, Immunology, Angiogenesis
Condiciones de envíoWet Ice
FuenteHuman
Para utilizar con (aplicación)Cell Culture
RecombinanteRecombinant
EspecieHuman
Unit Size100 µg
Contenido y almacenamiento
Lyophilized protein can be stored at 2-8°C dessicated. Once reconstituted, store in aliquots at ≤20°C. Avoid multiple freeze⁄thaw cycles.

Preguntas frecuentes

It looks like the recombinant protein vial I received from you is empty. Is this normal?

Gibco recombinant proteins are frequently formulated without carrier proteins or additives (e.g., BSA, HSA, sucrose, etc.) and no Gibco PeproTech recombinant protein contains a carrier protein. As a result, during lyophilization, the protein product may be deposited on the vial as a thin, and sometimes invisible, film instead of a pellet. The size of the pellet, if any, is not directly related to the quantity of the recombinant protein in the vial. Our quality control procedures assure that each vial contains the correct amount of product.

To ensure complete recovery of protein product, before opening a vial of lyophilized recombinant protein, we recommend centrifuging it in a microcentrifuge for 20-30 seconds to drive any protein that may be lodged in the cap or on the side to the bottom of the vial. After reconstitution, you can confirm the presence of product protein by running a small amount on SDS-PAGE. In general, a protein band with expected size should be visible with as little as 10 ng of protein loaded on an acrylamide gel.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

Why does my recombinant protein not show activity in my own experiment?

Assay time is critical. Each assay needs to beoptimized and performed at the peak response time. Different cells may respond differently to a growth factor or cytokine. We suggest repeating our QC assay using same indicator cells as suggested in the manual to see if you can obtain a similar response. In addition, serum may be masking the response. Serum starvation might be needed for certain types of assays.

How should I store the reconstituted recombinant proteins?

Protein solutions are generally not very stable when frozen at low concentration. Upon freeze and thaw, some proteins in the solution may stick to the wall of the container, which results in significant reduction of protein concentration if the starting concentration was low. Therefore, carrier proteins are used to reduce such loss. The most commonly used carrier proteins include bovine serum albumin (BSA), human serum albumin (HSA), or fetal bovine serum (FBS). These carrier proteins are generally used at 0.1% concentration. As a rule of thumb, if the concentration of the recombinant protein is less than 0.5 mg/mL, it is a good idea to add some carrier protein

How do I store my lyophilized recombinant protein?

Lyophilized proteins can typically be stored at 2 to 8 degrees C for several weeks, or stored dessicated at -20 degrees C for long-term storage.

Citations & References (7)

Citations & References
Abstract
IL-15 induces alloreactive CD28(-) memory CD8 T cell proliferation and CTLA4-Ig resistant memory CD8 T cell activation.
Authors:Traitanon O, Gorbachev A, Bechtel JJ, Keslar KS, Baldwin WM, Poggio ED, Fairchild RL,
Journal:
PubMed ID:24842641
'The presence of CD28(-) memory CD8 T cells in the peripheral blood of renal transplant patients is a risk factor for graft rejection and resistance to CTLA-4Ig induction therapy. In vitro analyses have indicated poor alloantigen-induced CD28(-) memory CD8 T cell proliferation, raising questions about mechanisms mediating their clonal expansion ... More
Fc receptor-like 3 protein expressed on IL-2 nonresponsive subset of human regulatory T cells.
Authors:Nagata S, Ise T, Pastan I
Journal:J Immunol
PubMed ID:19494275
'Fc receptor-like 3 (FCRL3) is a cell surface protein homologous to Fc receptors. The FCRL3 gene is present in humans but not in mice. We found that FCRL3 protein is expressed on 40% of human naturally occurring CD4(+) regulatory T (nTreg) cells (CD4(+)CD25(+)CD127(low)). Sorted nTreg cells with the surface phenotype ... More
Replicating adenovirus-simian immunodeficiency virus (SIV) recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques correlated with delayed acquisition following a repeated low-dose rectal SIV(mac251) challenge.
Authors:Xiao P, Patterson LJ, Kuate S, Brocca-Cofano E, Thomas MA, Venzon D, Zhao J, DiPasquale J, Fenizia C, Lee EM, Kalisz I, Kalyanaraman VS, Pal R, Montefiori D, Keele BF, Robert-Guroff M
Journal:J Virol
PubMed ID:22345466
'We have shown that sequential replicating adenovirus type 5 host range mutant human immunodeficiency virus/simian immunodeficiency virus (HIV/SIV) recombinant priming delivered first intranasally (i.n.) plus orally and then intratracheally (i.t.), followed by envelope protein boosting, elicits broad cellular immunity and functional, envelope-specific serum and mucosal antibodies that correlate with protection ... More
Interaction of Mycobacterium tuberculosis cell wall components with the human natural killer cell receptors NKp44 and Toll-like receptor 2.
Authors:Esin S, Counoupas C, Aulicino A, Brancatisano FL, Maisetta G, Bottai D, Di Luca M, Florio W, Campa M, Batoni G
Journal:Scand J Immunol
PubMed ID:23578092
'We have previously demonstrated that a soluble form of the human NK cell natural cytotoxicity receptor NKp44, binds to the surface of Mycobacterium tuberculosis (MTB). Herein, we investigated the interaction of MTB cell wall components (CWC) with NKp44 or with Toll-like receptor 2 (TLR2) and the role of NKp44 and ... More
IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis.
Authors:Martinez-Forero I, Garcia-Munoz R, Martinez-Pasamar S, Inoges S, Lopez-Diaz de Cerio A, Palacios R, Sepulcre J, Moreno B, Gonzalez Z, Fernandez-Diez B, Melero I, Bendandi M, Villoslada P
Journal:Eur J Immunol
PubMed ID:18200504
'T regulatory cells type 1 (Tr1 cells) are excellent candidates for cell therapy in multiple sclerosis (MS). The aim of our study was to assess the functional state of Tr1 cells and IL-10R signaling in patients with MS. Tr1 cells were induced in vitro by activation with anti-CD46 antibodies in ... More